Charles River Laboratories (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2002 | 03-2002 | 12-2001 | 09-2001 | 06-2001 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,712 | 135,398 | 58,271 | 78,303 | 28,416 |
| Receivables | 99,829 | 105,127 | 98,478 | 97,938 | 87,271 |
| Inventories | 39,454 | 39,125 | 39,056 | 39,206 | 36,607 |
| Income taxes - deferred | N/A | 8,701 | N/A | 2,055 | 2,055 |
| Other current assets | 15,713 | 5,786 | 14,349 | 7,080 | 7,306 |
| TOTAL | $239,708 | $294,137 | $210,154 | $224,582 | $161,655 |
| Non-Current Assets | |||||
| PPE Net | 169,088 | 153,901 | 155,919 | 149,249 | 141,807 |
| Investments And Advances | 3,187 | 3,123 | 3,002 | 2,908 | 2,799 |
| Intangibles | 107,107 | 90,674 | 90,374 | 90,984 | 89,480 |
| Other Non-Current Assets | 110,790 | 122,357 | 111,913 | 118,347 | 121,054 |
| TOTAL | $390,172 | $370,055 | $361,208 | $361,488 | $355,140 |
| Total Assets | $629,880 | $664,192 | $571,362 | $586,070 | $516,795 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 2,967 | N/A | 811 | 685 |
| Accounts payable and accrued liabilities | 12,240 | 11,777 | 13,868 | 9,408 | 9,501 |
| Accrued Expenses | 55,575 | 47,950 | 54,635 | 54,201 | 49,179 |
| Other current liabilities | 5,089 | N/A | 3,771 | N/A | N/A |
| TOTAL | $102,376 | $89,695 | $98,532 | $86,625 | $80,463 |
| Non-Current Liabilities | |||||
| Long Term Debt | 188,705 | 259,207 | 155,506 | 193,240 | 201,280 |
| Deferred Revenues | 22,168 | 23,160 | 22,210 | 16,786 | 15,953 |
| Other Non-Current Liabilities | 17,119 | 14,913 | 16,070 | 17,293 | 15,765 |
| TOTAL | $217,968 | $286,091 | $183,320 | $221,778 | $228,114 |
| Total Liabilities | $320,344 | $375,786 | $281,852 | $308,403 | $308,577 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 44,744 | 44,471 | 44,234 | 44,128 | 43,922 |
| Common Shares | 447 | 445 | 442 | 440 | 402 |
| Retained earnings | -269,072 | -285,400 | -283,168 | -292,085 | -302,606 |
| Other shareholders' equity | -14,447 | -17,245 | -16,673 | -16,448 | -20,169 |
| TOTAL | $309,536 | $288,406 | $289,510 | $277,667 | $208,218 |
| Total Liabilities And Equity | $629,880 | $664,192 | $571,362 | $586,070 | $516,795 |